PT - JOURNAL ARTICLE AU - Michel Y. Bergeron AU - Marko Savor AU - Lawrence Kryzanowski TI - Key Issues of Venture Capital Investing in Foreign Markets AID - 10.3905/jpe.2004.412335 DP - 2004 May 31 TA - The Journal of Private Equity PG - 47--54 VI - 7 IP - 3 4099 - https://pm-research.com/content/7/3/47.short 4100 - https://pm-research.com/content/7/3/47.full AB - The article presents the results of in-depth interviews with key biotechnology executives and emphasizes the issues and challenges American investors face when investing venture capital funds in the Canadian biotechnology sector. The results show that, although capital suppliers feel that the quality of Canadian science is credible and that its biotechnology industry presents interesting investment opportunities, they must be careful to adjust their due diligence procedures to account for the specific characteristics of the Canadian environment. It is argued that specialized U.S. venture capital investors can capitalize on the sectorņs opportunities as long as the key issues are properly addressed.